2021
DOI: 10.1159/000512722
|View full text |Cite
|
Sign up to set email alerts
|

A Novel Artificial Urinary Sphincter (VICTO®) for the Management of Postprostatectomy Urinary Incontinence: Description of the Surgical Technique and Preliminary Results from a Multicenter Series

Abstract: Aims: The objective of the study was to analyze short-term outcomes and safety profile of the newly designed artificial urinary sphincters (AUSs) VICTO® and VICTOplus®. Methods: Data from the implant of VICTO® or VICTOplus® AUSs on a series of consecutive male patients with stress urinary incontinence (SUI) following radical prostatectomy (RP) were retrospectively collected in 3 tertiary referral centers between May 2017 and December 2019. Patients were affected by moderate-severe genuine SUI (200–400 or >4… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(6 citation statements)
references
References 21 publications
0
5
0
1
Order By: Relevance
“…Another pre-connected device is the Victo AUS from the same company that created the Argus slings (Promedon SA). This sphincter is also designed to be adjustable, similar to their slings, resulting in a 76.4% dry rate and no explantations after one year in two available studies (45,46). However, these devices have not had FDA clearance but are available in many countries in Latin America, Europe, Asia, and Africa.…”
Section: Ausmentioning
confidence: 99%
“…Another pre-connected device is the Victo AUS from the same company that created the Argus slings (Promedon SA). This sphincter is also designed to be adjustable, similar to their slings, resulting in a 76.4% dry rate and no explantations after one year in two available studies (45,46). However, these devices have not had FDA clearance but are available in many countries in Latin America, Europe, Asia, and Africa.…”
Section: Ausmentioning
confidence: 99%
“…Due to its frequent complications in clinical use, such as urethral atrophy and mechanical failure, several such devices have followed, such as the Zephyr ZSI 375, 23,24 FlowSecure, 25,26 Adjustable continence therapy, 27,28 BR-SL-AS-904, 29 Periurethral constrictor, 30,31 and VICTO/VICTO+. 32,33 For electromechanically controllable AUS, the devices in the research phase are currently Tape mechanical occlusive device, 34 German artificial sphincter system, 35,36 and Closed Loop Control AUS. 37 As for AUS with SMAs, a Swiss medical technology company produced an advanced AUS system based on SMA filaments in a recent paper.…”
Section: Of Ausmentioning
confidence: 99%
“…While the retrospective analysis provided promising results, it is essential to recognize the need for further research and long-term follow-up studies to validate and establish the VICTO ® devices' long-term effectiveness and safety. As with any medical device, continued monitoring and evaluation are crucial to identify potential issues and optimize patient outcomes [5].…”
Section: Victomentioning
confidence: 99%
“…Devices such as the Zephyr 375 urinary sphincter, Victo, BR-SL-AS 904, and Conti ® have captured the attention of researchers and clinicians due to their potential to match or even surpass the efficacy of the AMS 800™. Despite their potential, the limited availability of scientific literature and data has hindered a robust comparison and evaluation of their effectiveness [4][5][6].…”
Section: Introductionmentioning
confidence: 99%